Alexandre C Pereira
Overview
Explore the profile of Alexandre C Pereira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
319
Citations
6634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roselli C, Surakka I, S Olesen M, Sveinbjornsson G, Marston N, Choi S, et al.
Nat Genet
. 2025 Mar;
57(3):539-547.
PMID: 40050429
Atrial fibrillation (AF) is the most common heart rhythm abnormality and is a leading cause of heart failure and stroke. This large-scale meta-analysis of genome-wide association studies increased the power...
2.
Ostrominski J, Claggett B, Jerosch-Herold M, Raja A, Day S, Russell M, et al.
JAMA Cardiol
. 2025 Mar;
PMID: 40042824
Importance: Valsartan has been shown to attenuate phenotypic progression among individuals with early-stage sarcomeric hypertrophic cardiomyopathy (HCM). Myocardial tissue characterization by cardiac magnetic resonance (CMR) imaging may enhance mechanistic insights,...
3.
Rasooly D, Giambartolomei C, Peloso G, Dashti H, Ferolito B, Golden D, et al.
Nat Cardiovasc Res
. 2025 Feb;
PMID: 39915329
Heart failure (HF) has limited therapeutic options. In this study, we differentiated the pathophysiological underpinnings of the HF subtypes-HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction...
4.
Butters A, Arnott C, Sweeting J, Claggett B, Cuomo A, Cuomo A, et al.
Circ Genom Precis Med
. 2025 Jan;
18(1):e004641.
PMID: 39851041
Background: Females with hypertrophic cardiomyopathy present at a more advanced stage of the disease and have a higher risk of heart failure and death. The factors behind these differences are...
5.
Fam B, Cadore N, Sbruzzi R, Feira M, Giudicelli G, de Almeida L, et al.
Front Immunol
. 2025 Jan;
15:1444620.
PMID: 39744633
Introduction: The COVID-19 pandemic had a widespread global impact and presented numerous challenges. The emergence of SARS-CoV-2 variants has changed transmission rates and immune evasion, possibly impacting the severity. This...
6.
Teixeira S, Rossi F, Patane J, Neyra J, Jensen A, Horta B, et al.
Sci Rep
. 2024 Nov;
14(1):28123.
PMID: 39548300
Despite the identification of numerous genetic variants affecting SBP in European populations, their applicability in admixed populations remains unclear. This study evaluates the predictive efficacy of a systolic blood pressure...
7.
Ahluwalia M, Liu J, Olivotto I, Parikh V, Ashley E, Michels M, et al.
JACC Heart Fail
. 2024 Nov;
13(2):332-343.
PMID: 39520446
Background: An improved understanding of the natural history in NYHA functional class I patients with obstructive hypertrophic cardiomyopathy (oHCM) is needed. Objectives: Using a multicenter registry (SHaRe [Sarcomeric Human Cardiomyopathy...
8.
Triozzi J, Yu Z, Giri A, Chen H, Wilson O, Ferolito B, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2440286.
PMID: 39453656
Importance: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have nephroprotective properties beyond those related to weight loss and glycemic control. Objective: To investigate the association of genetically proxied GLP-1RAs with...
9.
Taporoski T, Beijamini F, Alexandria S, Aaby D, Krieger J, von Schantz M, et al.
Sleep
. 2024 Oct;
48(3).
PMID: 39425983
Study Objectives: Sleep characteristics are associated with cardiovascular disease (CVD) risk and both sleep and CVD risk vary by gender. Our objective was to examine associations between polysomnographic sleep characteristics...
10.
Cesena F, Generoso G, Santos I, Pereira A, Bittencourt M, Santos R, et al.
Arq Bras Cardiol
. 2024 Aug;
121(7):e20240002.
PMID: 39166567
No abstract available.